EVGN ▲ +1.8% - Evogene Ltd. $EVGN EVGN - Evogene Responds to Dissident Shareholders: Transformation and Commercial Progress Provide a Clear Path Forward Evogene shares rose 1.8% following the company's response to dissident shareholders, in which management outlined its transformation efforts and commercial progress. The statement appears designed to address investor concerns and demonstrate that the company has a viable strategic direction forward. The modest gain suggests the market viewed the response favorably, though without seeing the full details of the company's claims, the move indicates cautious optimism among shareholders. 31-AUG-2026 08:01 AM ET